LY333531 [ruboxistaurin] treatment of symptomatic peripheral neuropathy in patients with diabetes
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Ruboxistaurin (Primary)
- Indications Diabetic neuropathies
- Focus Registrational; Therapeutic Use
- 23 Oct 2005 New trial record.